Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer
about
Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
Mirvetuximab Soravtansine and ...... e or Primary Peritoneal Cancer
@en
type
label
Mirvetuximab Soravtansine and ...... e or Primary Peritoneal Cancer
@en
prefLabel
Mirvetuximab Soravtansine and ...... e or Primary Peritoneal Cancer
@en
P1476
Phase I Study of Mirvetuximab ...... e or Primary Peritoneal Cancer
@en
P3098
NCT03552471
P4844
P580
2018-07-12T00:00:00Z
P582
2021-08-29T00:00:00Z